Early detection and diagnosis of inherited conditions in newborns and infants can lead to more effective therapies and better health outcomes Early detection and diagnosis of inherited conditions in ...

TAMPA, Fla. (WFLA) — Across eight studies focused on how COVID-19 impacted infant health and development, a meta-analysis found the pandemic virus led to higher risks of babies developing a variety of ...

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying ...

A new national study has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in ...

Researchers have found that babies born to mothers diagnosed with cannabis use disorders at delivery are more likely to have health problems when compared to babies born to mothers without the ...

NEW YORK, June 10, 2021 /PRNewswire/ -- Award-winning market research firm Fact.MR forecasts a healthy growth outlook for global newborn screening market over the forecast period of 2021 and 2031. The ...

When babies are very young, their brains are growing fast. That’s why it's important for parents to know what signs might indicate that something is off. Sometimes, neurological disorders impacting a ...

Sleep disorders in infants and children encompass a range of disturbances from irregular sleep patterns and prolonged sleep onset latency to frequent night-wakings and fragmented sleep cycles. These ...

Johnson & Johnson drug nipocalimab is in late-stage clinical testing in a rare neuromuscular disorder, and if it stays on track could become the third-to-market drug in its class for that indication.

Arowor Corp. develops biopharmaceuticals for rare infant disorders and disaster response plans. The Arowor Corp. pipeline is currently comprised of over one dozen candidates in various phases of ...